- Home
- ATAI vs HRTX Comparison
ATAI vs HRTX Comparison
Compare ATAI & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- HRTX
- Stock Information
- Founded
- ATAI 2018
- HRTX 1983
- Country
- ATAI Germany
- HRTX United States
- Employees
- ATAI N/A
- HRTX N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- ATAI Health Care
- HRTX Health Care
- Exchange
- ATAI Nasdaq
- HRTX Nasdaq
- Market Cap
- ATAI 280.2M
- HRTX 270.7M
- IPO Year
- ATAI 2021
- HRTX 1987
- Fundamental
- Price
- ATAI $1.99
- HRTX $1.73
- Analyst Decision
- ATAI Strong Buy
- HRTX Strong Buy
- Analyst Count
- ATAI 4
- HRTX 3
- Target Price
- ATAI $9.00
- HRTX $5.67
- AVG Volume (30 Days)
- ATAI 4.9M
- HRTX 1.2M
- Earning Date
- ATAI 03-27-2025
- HRTX 02-27-2025
- Dividend Yield
- ATAI N/A
- HRTX N/A
- EPS Growth
- ATAI N/A
- HRTX N/A
- EPS
- ATAI N/A
- HRTX N/A
- Revenue
- ATAI $331,000.00
- HRTX $137,737,000.00
- Revenue This Year
- ATAI $80.07
- HRTX $13.10
- Revenue Next Year
- ATAI N/A
- HRTX $14.03
- P/E Ratio
- ATAI N/A
- HRTX N/A
- Revenue Growth
- ATAI N/A
- HRTX 12.13
- 52 Week Low
- ATAI $1.03
- HRTX $1.04
- 52 Week High
- ATAI $2.85
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- ATAI 51.96
- HRTX 52.86
- Support Level
- ATAI $1.94
- HRTX $1.63
- Resistance Level
- ATAI $2.16
- HRTX $1.83
- Average True Range (ATR)
- ATAI 0.34
- HRTX 0.10
- MACD
- ATAI -0.03
- HRTX -0.01
- Stochastic Oscillator
- ATAI 48.38
- HRTX 41.94
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.